title: Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002.
authors.affiliation: Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. knezevic@who.int
authors.forename: I
authors.initials: I
authors.lastname: Knezevic
authors.forename: E
authors.initials: E
authors.lastname: Griffiths
authors.forename: F
authors.initials: F
authors.lastname: Reigel
authors.forename: R
authors.initials: R
authors.lastname: Dobbelaer
mesh_terms: D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology; D005060:Europe; D007880:Legislation, Drug; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D013849:Thimerosal / Q000009:adverse effects*; D014481:United States; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal